Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
COURAGE-ALS Trial: Reldesemtiv Fails to Slow ALS Progression
April 2025
Reldesemtiv fails to slow ALS progression in COURAGE-ALS trial, highlighting challenges in ALS treatment development.
Read more
19 Dec 2024
20% Relapse Risk After Discontinuing Therapy in Stable Multiple Sclerosis
Discontinuing first-line therapy in stable multiple sclerosis can trigger inflammation recurrence in 20% of patients.
17 Dec 2024
Predictors of Death or Disability in Babies with Hypoxic-Ischaemic Encephalopathy
Key EEG, MRI, and clinical findings predict outcomes in neonates with HIE treated with hypothermia, aiding prognosis.
15 Dec 2024
New Insights into Depression: Skull Bone Marrow, Sinuses, and Inflammation
Imaging reveals how skull regions mediate brain-periphery immune crosstalk in depression, uncovering new therapeutic targets.
14 Dec 2024
Long-Term Success with Cyclophosphamide in Refractory Myasthenia Gravis
Cyclophosphamide offers rapid remission and long-term benefits in high-risk myasthenia gravis, reducing corticosteroid reliance and injectable therapies.
13 Dec 2024
Antipsychotics Linked to Worsening Behaviour in Long-Term Care Residents
Antipsychotics may worsen behavioral symptoms in long-term care residents, according to a large Canadian study. Researchers found a significant association between antipsychotic use and behavioral deterioration, urging caution in prescribing these medications.
10 Dec 2024
COVID-19 Spike Protein Persists in Brain Tissues for Years
Study finds SARS-CoV-2 spike protein persists in brain tissues for years, with vaccines reducing this accumulation by 50%.
9 Dec 2024
Beta Blockers May Slow Progression of Huntington Disease
Study links Beta blocker therapy to delayed motor onset and slower progression in Huntington disease, suggesting therapeutic benefits.
7 Dec 2024
100% Accuracy in Diagnosing Stroke Types with Novel MRI
Low-field 0.23-T MRI with a novel sequence achieves 100% accuracy in stroke diagnosis within 24 hours of onset.
Loading posts...
« Previous
1
…
6
7
8
9
10
…
38
Next »